Dr. Choyke on Recent Developments in Imaging for Prostate Cancer

November 25, 2020
Peter Choyke, MD, FACR

Peter L. Choyke, MD, FACR, discusses recent developments in imaging for prostate cancer.

Peter L. Choyke, MD, FACR, ​chief, Molecular Imaging Branch, senior investigator, head, Imaging Section, National Cancer Institute, discusses recent developments in imaging for prostate cancer.

For a number of years, imaging ​modalities for prostate cancer weren't particularly intriguing diagnostic tool​s, Choyke says. ​Historically, bone scans and CT scans have been used, though both methods lacked the sensitivity needed to stage these patients.

Recently, however, numerous novel PET agents have dramatically improved the sensitivity for detecting ​metastatic or recurrent sites of prostate cancer, explains Choyke. It is now known that even in case​s of very low prostate-specific antigen recurrences, sites of disease can be reliably detect​ed using this modern method, Choyke concludes.

Related Content:

Prostate Cancer

x